Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Diabetes Treatment and Management, Heart Failure Treatment and Management, Acute Myocardial Infarction Research, and Pancreatic function and diabetes.
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
<scp>DECLARE‐TIMI</scp> 58: Participants’ baseline characteristics
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial